Clinical Trial Update: A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men [Phase 1]

View source ↗

Summary

This Phase 1 study assessed blood concentrations of rosuvastatin when co-administered with GW856553 in healthy men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease

Drugs mentioned

• GW856553
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis, Cardiovascular Disease | Phase 1 | Status: COMPLETED